Molecular mechanisms of remodeling in human atrial fibrillation.

An important acknowledgement of the last several years is that atrial fibrillation (AF) modifies the electrical properties of the atrium in a way that promotes its occurrence and maintenance. This arrhythmogenic electrophysiological remodeling is well established, but can not explain by itself that 'AF begets AF'. This review describes molecular changes involving rapid functional alterations and slower changes in protein expression that cause electrical remodeling and contractile dysfunction in AF. An important molecular feature of AF is the reduction in L-type Ca(2+) channel function and protein expression. This reduction may serve to protect the cell against a potentially lethal Ca(2+) overload resulting from the increased activation rate in AF. Further, the review discusses the possible role of proteolytic systems, notably the calpains, as a mechanism linking Ca(2+) overload to reduced protein expression. Thus, it appears that the elaborate molecular changes in AF are directed primarily at protecting the myocyte from cellular stress. However, such early protection occurs at the expense of electrophysiological changes that promote the long-term maintenance of AF.

[1]  D. Green,et al.  Stress management - heat shock protein-70 and the regulation of apoptosis. , 2001, Trends in cell biology.

[2]  M. Hori,et al.  Intracellular calcium level required for calpain activation in a single myocardial cell. , 2001, Journal of molecular and cellular cardiology.

[3]  S. Nattel,et al.  Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation. , 1999, Cardiovascular research.

[4]  U Schotten,et al.  Cellular Mechanisms of Depressed Atrial Contractility in Patients With Chronic Atrial Fibrillation , 2001, Circulation.

[5]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[6]  B. R. Jewell,et al.  Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. , 1980, Progress in biophysics and molecular biology.

[7]  P. Coumel,et al.  Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. , 1982, International journal of cardiology.

[8]  K. Shirato,et al.  Mechanisms of coronary microvascular dilation induced by the activation of pertussis toxin-sensitive G proteins are vessel-size dependent. Heterogeneous involvement of nitric oxide pathway and ATP-sensitive K+ channels. , 1997, Circulation research.

[9]  M. Allessie,et al.  Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. , 2001, Journal of molecular and cellular cardiology.

[10]  K. Arakawa,et al.  Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. , 2000, Circulation.

[11]  S. Huang,et al.  Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. , 1999, Journal of the American College of Cardiology.

[12]  D. Atar,et al.  Role of troponin I proteolysis in the pathogenesis of stunned myocardium. , 1997, Circulation research.

[13]  Zhang Ml Calcium activated neutral protease and its endogenous inhibitor , 1998 .

[14]  H. Kawasaki,et al.  Calcium‐activated neutral protease and its endogenous inhibitor Activation at the cell membrane and biological function , 1987, FEBS letters.

[15]  J. Olgin,et al.  Inhibition of the Na+/H+ Exchanger Delays the Development of Rapid Pacing–Induced Atrial Contractile Dysfunction , 2001, Circulation.

[16]  M. Allessie,et al.  Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. , 2000, Cardiovascular research.

[17]  P. L. Becker,et al.  Gs and adenylyl cyclase in transverse tubules of heart: implications for cAMP-dependent signaling. , 1999, American journal of physiology. Heart and circulatory physiology.

[18]  M. Rosen,et al.  The Relationship of Human Atrial Cellular Electrophysiology to Clinical Function and Ultrastructure , 1983, Circulation research.

[19]  F. Di Lisa,et al.  Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload. , 1996, Circulation.

[20]  H. Crijns,et al.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[21]  T. Pham,et al.  Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. , 1982, The American journal of cardiology.

[22]  H. Crijns,et al.  Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. , 1996, Archives of internal medicine.

[23]  D. Atsma,et al.  Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. , 1995, Circulation research.

[24]  S. Nattel,et al.  Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. , 2001, Cardiovascular research.

[25]  John Calvin Reed,et al.  Myocardial cell death in fibrillating and dilated human right atria. , 1999, Journal of the American College of Cardiology.

[26]  J A ABILDSKOV,et al.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[27]  C. Pandozi,et al.  Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. , 1998, Circulation.

[28]  P. Vardas,et al.  Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence. , 2000, Cardiovascular research.

[29]  D. Green,et al.  Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. , 1999, Blood.

[30]  Douglas L. Jones,et al.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.

[31]  S Nattel,et al.  Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling. , 2000, American journal of physiology. Heart and circulatory physiology.

[32]  L. Tsai,et al.  Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.

[33]  I. V. Van Gelder,et al.  Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. , 1999, Cardiovascular research.

[34]  Z. Papp,et al.  Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart. , 2000, Cardiovascular research.

[35]  K. Blomgren,et al.  A possible physiological role of the Ca-dependent protease calpain and its inhibitor calpastatin on the Ca current in guinea pig myocytes , 1988, Pflügers Archiv.

[36]  M. Allessie,et al.  Altered Pattern of Connexin40 Distribution in Persistent Atrial Fibrillation in the Goat , 1998, Journal of cardiovascular electrophysiology.

[37]  M. Allessie,et al.  Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. , 2000, Journal of molecular and cellular cardiology.

[38]  M R Franz,et al.  Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. , 1997, Journal of the American College of Cardiology.

[39]  W. Manning,et al.  Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[40]  R. Tieleman,et al.  Alterations in Gene Expression of Proteins Involved in the Calcium Handling in Patients with Atrial Fibrillation , 1999, Journal of cardiovascular electrophysiology.

[41]  F. Di Lisa,et al.  Troponin T cross-linking in human apoptotic cardiomyocytes. , 1997, The American journal of pathology.

[42]  H. Crijns,et al.  Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. , 2001, Journal of the American College of Cardiology.

[43]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[44]  U Ravens,et al.  Molecular Basis of Downregulation of G-Protein–Coupled Inward Rectifying K+ Current (IK,ACh) in Chronic Human Atrial Fibrillation: Decrease in GIRK4 mRNA Correlates With Reduced IK,ACh and Muscarinic Receptor–Mediated Shortening of Action Potentials , 2001, Circulation.

[45]  H. Crijns,et al.  Endothelin System in Human Persistent and Paroxysmal Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.

[46]  S Nattel,et al.  Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. , 1997, Circulation.

[47]  A. Goette,et al.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. , 2000, Circulation.

[48]  M. Allessie,et al.  Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.

[49]  Simon C Watkins,et al.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.

[50]  F. Morady,et al.  Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. , 1997, Circulation.

[51]  A. Goette,et al.  Electrical remodeling in atrial fibrillation. Time course and mechanisms. , 1996, Circulation.

[52]  J Haaksma,et al.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.

[53]  S. Nattel,et al.  The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. , 1999, Circulation.

[54]  J. Olgin,et al.  Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. , 2000, Circulation.

[55]  M. Courtemanche,et al.  Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. , 1998, The American journal of physiology.

[56]  M. Zhang [Calcium activated neutral protease and its endogenous inhibitor]. , 1998, Sheng li ke xue jin zhan [Progress in physiology].

[57]  H. C. Burger,et al.  Experimental and laboratory reports: Comparison of three different systems of vectorcardiography , 1959 .

[58]  A J Levi,et al.  Role of Intracellular Sodium Overload in the Genesis of Cardiac Arrhythmias , 1997, Journal of cardiovascular electrophysiology.

[59]  C. Zuppan,et al.  Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. , 1995, The New England journal of medicine.

[60]  A. L. Wit,et al.  Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. , 1984, Circulation.

[61]  F. Morady,et al.  Short-term effect of atrial fibrillation on atrial contractile function in humans. , 1999, Circulation.

[62]  W. Catterall,et al.  Differential Proteolysis of the Full‐Length Form of the L‐Type Calcium Channel α1 Subunit by Calpain , 1994, Journal of neurochemistry.

[63]  A. Goette,et al.  Expression and activity of ectopeptidases in fibrillating human atria. , 2001, Journal of molecular and cellular cardiology.

[64]  M. Lerch,et al.  Sphincter stencels and gallstone migration through the biliary tract , 1993, The Lancet.

[65]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .

[66]  A. Wear CIRCULATION , 1964, The Lancet.

[67]  J. Nerbonne,et al.  Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. , 1997, Circulation research.

[68]  S H Lee,et al.  Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. , 1999, Cardiovascular research.

[69]  S. Nattel,et al.  Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. , 1998, Circulation.

[70]  G. Christensen,et al.  Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. , 1996, Circulation.

[71]  I. V. Van Gelder,et al.  Molecular adaptations in human atrial fibrillation : mechanisms of protein remodeling , 2000 .

[72]  R. Hauer,et al.  Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. , 2000, Circulation.

[73]  Marcel Leist,et al.  Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.

[74]  M. Maki,et al.  Calpastatin domain L is involved in the regulation of L-type Ca2+ channels in guinea pig cardiac myocytes. , 2000, Biochemical and biophysical research communications.

[75]  M. Allessie,et al.  Structural changes of atrial myocardium during chronic atrial fibrillation. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[76]  J. Nerbonne,et al.  Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.

[77]  J. Olgin,et al.  Basic mechanisms of atrial fibrillation. , 2004, Cardiology clinics.

[78]  S Nattel,et al.  Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. , 1999, Circulation research.

[79]  J. Olgin,et al.  Role of the Na(+)/H(+) exchanger in short-term atrial electrophysiological remodeling. , 2000, Circulation.

[80]  D. Todd,et al.  Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. , 2000, Circulation.

[81]  S. Nattel,et al.  Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. , 1998, Circulation.

[82]  R. Lane,et al.  A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells. , 1992, Experimental cell research.

[83]  S Nattel,et al.  Basic mechanisms of atrial fibrillation--very new insights into very old ideas. , 2000, Annual review of physiology.

[84]  Michael R. Rosen,et al.  Pathophysiology and Prevention of Atrial Fibrillation , 2001, Circulation.

[85]  M. Yano,et al.  Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. , 1999, Journal of the American College of Cardiology.

[86]  S Nattel,et al.  Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. , 1999, Cardiovascular research.

[87]  R F Bosch,et al.  Ionic mechanisms of electrical remodeling in human atrial fibrillation. , 1999, Cardiovascular research.

[88]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[89]  H. Crijns,et al.  Ion Channel Remodeling Is Related to Intraoperative Atrial Effective Refractory Periods in Patients With Paroxysmal and Persistent Atrial Fibrillation , 2001, Circulation.

[90]  A. Stracher Calpain Inhibitors as Therapeutic Agents in Nerve and Muscle Degeneration , 1999, Annals of the New York Academy of Sciences.

[91]  M. Allessie,et al.  Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation. , 1997, The American journal of pathology.

[92]  D P Zipes,et al.  Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. , 1996, Circulation.

[93]  W. Manning,et al.  Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. , 1989, Journal of the American College of Cardiology.

[94]  S Nattel,et al.  Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. , 1997, Circulation research.

[95]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[96]  S Nattel,et al.  Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.

[97]  J. Saffitz,et al.  Proteolysis of connexin43-containing gap junctions in normal and heat-stressed cardiac myocytes. , 1998, Cardiovascular research.

[98]  C. Tai,et al.  Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs. , 1998, Circulation.

[99]  S Nattel,et al.  Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs. , 1996, The American journal of physiology.

[100]  T. Ryan,et al.  Safety and efficacy of percutaneous coronary interventions performed immediately after diagnostic catheterization in northern new england and comparison with similar procedures performed later. , 2000, The American journal of cardiology.

[101]  S Nattel,et al.  Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. , 1997, The American journal of physiology.